GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,258 | -7.2% | 64 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,433 | +0.7% | 64 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,417 | -10.9% | 64 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,712 | +35.6% | 64 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 64 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 64 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -66.7% | 64 | -57.0% | 0.00% | -100.0% |
| Q4 2021 | $6,000 | 0.0% | 149 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $6,000 | -14.3% | 147 | -16.5% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | +16.7% | 176 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | 0.0% | 176 | +22.2% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | +200.0% | 144 | +125.0% | 0.00% | +100.0% |
| Q3 2020 | $2,000 | 0.0% | 64 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | 0.0% | 64 | -37.9% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 103 | +635.7% | 0.00% | – |
| Q4 2019 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |